Ethical Compliance
JUBILANT PHARMOVA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.4%
Debt
29.6%
Liquidity
8.3%
Revenue
Debt
Liquidity
0.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals | ₹5,043.60 |
| Contract Research and Development Services | ₹1,601.20 |
| other income | ₹42.40 |
| other operating income | ₹58.10 |
Questionable
INR Crores
| investment gain | ₹0.20 |
Non Compliant
INR Crores
| Interest Income | ₹26.10 |
INR Crores
| Revenue from Questionable Sources: | ₹0.20 |
| Revenue from Non Compliant Sources: | ₹26.10 |
| Total: | ₹26.30 |
| Total Revenue: | ₹6,771.60 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹26.30
₹6,771.60
= 0.4%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
